Net profit of Syncom Formulations (India) rose 106.42% to Rs 15.75 crore in the quarter ended June 2025 as against Rs 7.63 crore during the previous quarter ended June 2024. Sales rose 33.97% to Rs 116.90 crore in the quarter ended June 2025 as against Rs 87.26 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 116.90 | 87.26 | 34 |
OPM % | 13.52 | 11.98 | - |
PBDT | 21.59 | 11.40 | 89 |
PBT | 20.25 | 10.10 | 100 |
NP | 15.75 | 7.63 | 106 |
Powered by Capital Market - Live News